参松养心胶囊治疗扩张型心肌病窦性心律震荡现象的临床观察和机理探讨.pdfVIP

  • 3
  • 0
  • 约5.9万字
  • 约 48页
  • 2017-07-20 发布于贵州
  • 举报

参松养心胶囊治疗扩张型心肌病窦性心律震荡现象的临床观察和机理探讨.pdf

参松养心胶囊治疗扩张型心肌病窦性心律震荡现象的临床观察和机理探讨

提 要 目的:通过观察参松养心胶囊治疗扩张型心肌病(DCM)窦性心律震荡现象的临 床疗效并探讨其作用机制,从而为治疗及改善扩张型心肌病的预后提供一条新的理论 基础。方法:选择确诊为扩张型心肌病的50例患者,随机分为基础治疗组和参松养心 胶囊治疗组。基础治疗组25例,给予常规西药治疗;参松养心胶囊治疗组25例,在常 规西药治疗的基础上加用参松养心胶囊,一次四粒,一天三次。两组患者分别于服药 前及服药3个月后行:24h动态心电图检查计算窦性心律震荡(HRT)的阴性率、震荡 初始(TO)及震荡斜率(TS)、24h室性早搏数目,心电图计算QT离散度(QTd),心脏 彩超测定左室射血分数(LVEF)、左室舒张末内径(LVEDD)、每搏输出量(SV),6分 钟步行试验,汉密顿抑郁量表积分,肝、肾功及电解质,从而评判其疗效及安全性。 结果:治疗前2组患者各项指标未见明显差异(P >0.05);治疗3个月后,临床研究 显示:(1)2组HRT阴性率、TO值、TS值、24h室早数目、QTd均较前显著改善(P <0.01), 并且参松养心胶囊治疗组较基础治疗组改善更优(P <0.05);(2)基础治疗组、参 松养心胶囊治疗组对LVEF、LVEDD、SV均有明显改善(P <0.05),但2组间无统计学 差异(P >0.05);(3)参松养心胶囊治疗组六分钟步行试验、汉密顿抑郁量表积分 均优于基础治疗组(P <0.05);(4)肝、肾功及电解质均较前无明显差异(P >0.05)。 结论:参松养心胶囊可改善扩张型心肌自主神经功能的紊乱,为治疗及改善扩张型心 肌病的预后,提供了一条新的理论依据。 关键词 扩张型心肌病;参松养心胶囊;室性期前收缩;窦性心律震荡 Clinical Study on the effect of shensongyangxin capsule treating HRT in patients with dilated cardiomyopathy and the discussion of the mechanism Speciality: Internal Medicine of Traditional Chinese Medicine Author: Bi Yongzhi Tutor: Prof.Liu Xiangqun Abstract Objective:To observe the clincical effect of shensongyangxin capsule treating heart rate turbulence in patients with dilated cardiomyopathy and explore its mechanism in order to provide a new theoretical basis for the treatment and the improvement of the prognosis.Methods:According to the standards,50 cases of hospital inpatients or outpatients diagnosed with dilated cardiomyopathy were divided randomly into two groups:basic treatment group and shensongyangxin capsule treating group.The basic treatmennt group with 25 cases were dosed with routine western medicine,and the shensongyangxin capsule treating gr

文档评论(0)

1亿VIP精品文档

相关文档